Supplier of key reagents for drug development.

+86-15801534258
info@nebulabio.cn
Product Name NebuSelect™ Recombinant Human EPHB2, His-tag
Catalog Number NBL-240710
Alias/Synonyms EPHB2; DRT; ERK; HEK5; TYRO5; CAPB; EK5; EPHT3; PCBC; Cek5; EphB2; EPHT3MGC87492; Nuk; Qek2; Sek3
Appearance see COA
Molecule Weight Val19-Leu543
CAS N/A
Solubility Water Soluble
Storage Short term 4℃; Long term -20℃.
Shelf Life 2 years
Additional info 1 P29323-1
Additional info 2
Catalog Numbe Size Price Inventory Level  
NBL-240710-100ug 100ug Inquire Inquire
NBL-240710-1mg 1mg Inquire Inquire
NBL-240710-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human EPHB2, His-tag


Catalog#:

NBL-240710


Description:

NebuSelect™ Recombinant Human EPHB2, His-tag(Cat#NBL-240710) is expressed in HEK293 with His tag at the C-Terminus.It contains Val19-Leu543.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 59.2 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.


Target Name:

EPHB2; DRT; ERK; HEK5; TYRO5; CAPB; EK5; EPHT3; PCBC; Cek5; EphB2; EPHT3MGC87492; Nuk; Qek2; Sek3


Target Information:

EphB2, a receptor tyrosine kinase for ephrin ligands, is overexpressed in various cancers and plays an important role in tumor progression. EPHB2 promotes endothelial-mesenchymal transition (EMT) and elicits associated pathologic characteristics of glioblastoma multiforme (GBM) such as invasion and migration. EPHB2 is epigenetically overexpressed in hypoxia, a condition highly prevalent in malignancy. Furthermore, HIF-2α is required for EPHB2 stabilization by hypoxia.


Amino Acid Sequence: 

Val19-Leu543


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

Top-selling Items